Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Uranium Effect on Osteocytic Cells In Vitro.

Hurault L, Creff G, Hagège A, Santucci-Darmanin S, Pagnotta S, Farlay D, Den Auwer C, Pierrefite-Carle V, Carle GF.

Toxicol Sci. 2019 Jul 1;170(1):199-209. doi: 10.1093/toxsci/kfz087.

PMID:
31120128
2.

Role of autophagy in osteosarcoma.

Camuzard O, Santucci-Darmanin S, Carle GF, Pierrefite-Carle V.

J Bone Oncol. 2019 Apr 3;16:100235. doi: 10.1016/j.jbo.2019.100235. eCollection 2019 Jun. Review.

3.

Autophagy Involvement in Aseptic Loosening of Arthroplasty Components.

Camuzard O, Breuil V, Carle GF, Pierrefite-Carle V.

J Bone Joint Surg Am. 2019 Mar 6;101(5):466-472. doi: 10.2106/JBJS.18.00479. No abstract available.

PMID:
30845042
4.

[Autophagy, a key process in bone homeostasis].

Camuzard O, Santucci-Darmanin S, Carle GF, Pierrefite-Carle V.

Med Sci (Paris). 2017 Mar;33(3):221-224. doi: 10.1051/medsci/20173303005. Epub 2017 Apr 3. French. No abstract available.

5.

Natural uranium impairs the differentiation and the resorbing function of osteoclasts.

Gritsaenko T, Pierrefite-Carle V, Lorivel T, Breuil V, Carle GF, Santucci-Darmanin S.

Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):715-726. doi: 10.1016/j.bbagen.2017.01.008. Epub 2017 Jan 9.

PMID:
28089586
6.

Sex-specific autophagy modulation in osteoblastic lineage: a critical function to counteract bone loss in female.

Camuzard O, Santucci-Darmanin S, Breuil V, Cros C, Gritsaenko T, Pagnotta S, Cailleteau L, Battaglia S, Panaïa-Ferrari P, Heymann D, Carle GF, Pierrefite-Carle V.

Oncotarget. 2016 Oct 11;7(41):66416-66428. doi: 10.18632/oncotarget.12013.

7.

Effect of natural uranium on the UMR-106 osteoblastic cell line: impairment of the autophagic process as an underlying mechanism of uranium toxicity.

Pierrefite-Carle V, Santucci-Darmanin S, Breuil V, Gritsaenko T, Vidaud C, Creff G, Solari PL, Pagnotta S, Al-Sahlanee R, Auwer CD, Carle GF.

Arch Toxicol. 2017 Apr;91(4):1903-1914. doi: 10.1007/s00204-016-1833-5. Epub 2016 Sep 1.

PMID:
27585666
8.

Pelvic fractures: epidemiology, consequences, and medical management.

Breuil V, Roux CH, Carle GF.

Curr Opin Rheumatol. 2016 Jul;28(4):442-7. doi: 10.1097/BOR.0000000000000293. Review.

PMID:
27077891
9.

Autophagy in bone: Self-eating to stay in balance.

Pierrefite-Carle V, Santucci-Darmanin S, Breuil V, Camuzard O, Carle GF.

Ageing Res Rev. 2015 Nov;24(Pt B):206-17. doi: 10.1016/j.arr.2015.08.004. Epub 2015 Aug 28. Review.

PMID:
26318060
10.

Autophagy in osteoblasts is involved in mineralization and bone homeostasis.

Nollet M, Santucci-Darmanin S, Breuil V, Al-Sahlanee R, Cros C, Topi M, Momier D, Samson M, Pagnotta S, Cailleteau L, Battaglia S, Farlay D, Dacquin R, Barois N, Jurdic P, Boivin G, Heymann D, Lafont F, Lu SS, Dempster DW, Carle GF, Pierrefite-Carle V.

Autophagy. 2014;10(11):1965-77. doi: 10.4161/auto.36182.

11.

Autophagy and SQSTM1 on the RHOA(d) again: emerging roles of autophagy in the degradation of signaling proteins.

Belaid A, Ndiaye PD, Cerezo M, Cailleteau L, Brest P, Klionsky DJ, Carle GF, Hofman P, Mograbi B.

Autophagy. 2014 Feb;10(2):201-8. doi: 10.4161/auto.27198. Epub 2013 Nov 26.

12.

Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

Belaid A, Cerezo M, Chargui A, Corcelle-Termeau E, Pedeutour F, Giuliano S, Ilie M, Rubera I, Tauc M, Barale S, Bertolotto C, Brest P, Vouret-Craviari V, Klionsky DJ, Carle GF, Hofman P, Mograbi B.

Cancer Res. 2013 Jul 15;73(14):4311-22. doi: 10.1158/0008-5472.CAN-12-4142. Epub 2013 May 23.

13.

Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model.

Duarte S, Momier D, Baqué P, Casanova V, Loubat A, Samson M, Guigonis JM, Staccini P, Saint-Paul MC, De Lima MP, Carle GF, Pierrefite-Carle V.

Stem Cells. 2013 Mar;31(3):423-32. doi: 10.1002/stem.1292.

14.

Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect.

Duarte S, Loubat A, Momier D, Topi M, Faneca H, Pedroso de Lima MC, Carle GF, Pierrefite-Carle V.

Oncol Rep. 2012 Sep;28(3):1057-62. doi: 10.3892/or.2012.1904. Epub 2012 Jul 6.

PMID:
22825753
15.

Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes.

Verron E, Loubat A, Carle GF, Vignes-Colombeix C, Strazic I, Guicheux J, Rochet N, Bouler JM, Scimeca JC.

Biochem Pharmacol. 2012 Mar 1;83(5):671-9. doi: 10.1016/j.bcp.2011.12.015. Epub 2011 Dec 19.

PMID:
22202439
16.

Monocytes differentiation upon treatment with a peptide corresponding to the C-terminus of activated T cell-expressed Tirc7 protein.

Mouline CC, Beranger GE, Schmid-Antomarchi H, Quincey D, Momier D, Boukhechba F, Carle GF, Rochet N, Scimeca JC.

J Cell Physiol. 2012 Aug;227(8):3088-98. doi: 10.1002/jcp.23059.

PMID:
22015593
17.

Fate of bone marrow stromal cells in a syngenic model of bone formation.

Boukhechba F, Balaguer T, Bouvet-Gerbettaz S, Michiels JF, Bouler JM, Carle GF, Scimeca JC, Rochet N.

Tissue Eng Part A. 2011 Sep;17(17-18):2267-78. doi: 10.1089/ten.TEA.2010.0461. Epub 2011 Jun 14.

PMID:
21539494
18.

Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition.

Breuil V, Amri EZ, Panaia-Ferrari P, Testa J, Elabd C, Albert-Sabonnadière C, Roux CH, Ailhaud G, Dani C, Carle GF, Euller-Ziegler L.

Joint Bone Spine. 2011 Dec;78(6):611-5. doi: 10.1016/j.jbspin.2011.02.002. Epub 2011 Mar 26.

PMID:
21441053
19.

Osteoclast activity modulates B-cell development in the bone marrow.

Mansour A, Anginot A, Mancini SJ, Schiff C, Carle GF, Wakkach A, Blin-Wakkach C.

Cell Res. 2011 Jul;21(7):1102-15. doi: 10.1038/cr.2011.21. Epub 2011 Feb 15.

20.

Osteoclastic differentiation of mouse and human monocytes in a plasma clot/biphasic calcium phosphate microparticles composite.

Mouline CC, Quincey D, Laugier JP, Carle GF, Bouler JM, Rochet N, Scimeca JC.

Eur Cell Mater. 2010 Dec 10;20:379-92.

21.

Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance.

Augier S, Ciucci T, Luci C, Carle GF, Blin-Wakkach C, Wakkach A.

J Immunol. 2010 Dec 15;185(12):7165-73. doi: 10.4049/jimmunol.0902583. Epub 2010 Nov 15.

22.

Tumor microenvironment modifications induced by soluble VEGF receptor expression in a rat liver metastasis model.

Bertin S, Mohsen-Kanson T, Baqué P, Gavelli A, Momier D, Anjuere F, Carle GF, Pierrefite-Carle V.

Cancer Lett. 2010 Dec 8;298(2):264-72. doi: 10.1016/j.canlet.2010.07.017. Epub 2010 Aug 10.

PMID:
20702033
23.

Biphasic calcium phosphate microparticles for bone formation: benefits of combination with blood clot.

Balaguer T, Boukhechba F, Clavé A, Bouvet-Gerbettaz S, Trojani C, Michiels JF, Laugier JP, Bouler JM, Carle GF, Scimeca JC, Rochet N.

Tissue Eng Part A. 2010 Nov;16(11):3495-505. doi: 10.1089/ten.TEA.2010.0227. Epub 2010 Aug 17.

PMID:
20590522
24.

Immune changes in post-menopausal osteoporosis: the Immunos study.

Breuil V, Ticchioni M, Testa J, Roux CH, Ferrari P, Breittmayer JP, Albert-Sabonnadière C, Durant J, De Perreti F, Bernard A, Euller-Ziegler L, Carle GF.

Osteoporos Int. 2010 May;21(5):805-14. doi: 10.1007/s00198-009-1018-7. Epub 2009 Oct 30.

PMID:
19876583
25.

Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement.

Rochet N, Balaguer T, Boukhechba F, Laugier JP, Quincey D, Goncalves S, Carle GF.

Biomaterials. 2009 Sep;30(26):4260-7. doi: 10.1016/j.biomaterials.2009.04.044. Epub 2009 May 23.

PMID:
19481081
26.

Human primary osteocyte differentiation in a 3D culture system.

Boukhechba F, Balaguer T, Michiels JF, Ackermann K, Quincey D, Bouler JM, Pyerin W, Carle GF, Rochet N.

J Bone Miner Res. 2009 Nov;24(11):1927-35. doi: 10.1359/jbmr.090517.

27.

Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts.

Bouvet-Gerbettaz S, Merigo E, Rocca JP, Carle GF, Rochet N.

Lasers Surg Med. 2009 Apr;41(4):291-7. doi: 10.1002/lsm.20759.

PMID:
19347941
28.

Gene polymorphisms and osteoporotic fractures: a study in postmenopausal French women.

Breuil V, Quincey D, Testa J, Roux CH, Albert C, Mroueh Z, Chami-Stemman H, Brocq O, Grisot C, Euller-Ziegler L, Carle GF.

Joint Bone Spine. 2009 May;76(3):317-9. doi: 10.1016/j.jbspin.2008.09.016. Epub 2009 Mar 18. No abstract available.

PMID:
19299182
29.

Specific expression of BMP2/4 ortholog in biomineralizing tissues of corals and action on mouse BMP receptor.

Zoccola D, Moya A, Béranger GE, Tambutté E, Allemand D, Carle GF, Tambutté S.

Mar Biotechnol (NY). 2009 Mar-Apr;11(2):260-9. doi: 10.1007/s10126-008-9141-6. Epub 2008 Sep 16.

PMID:
18795368
30.

Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts.

Wakkach A, Mansour A, Dacquin R, Coste E, Jurdic P, Carle GF, Blin-Wakkach C.

Blood. 2008 Dec 15;112(13):5074-83. doi: 10.1182/blood-2008-01-132787. Epub 2008 Sep 2.

31.

Characterization of IL-10-secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker.

Wakkach A, Augier S, Breittmayer JP, Blin-Wakkach C, Carle GF.

J Immunol. 2008 May 1;180(9):6054-63.

32.

[Cellular strategies in bone tissue engineering: a review].

Trojani C, Balaguer T, Boukhechba F, Carle GF, Boileau P, Rochet N.

Rev Chir Orthop Reparatrice Appar Mot. 2008 Feb;94(1):1-11. doi: 10.1016/j.rco.2007.11.001. Epub 2008 Feb 20. Review. French.

PMID:
18342024
33.

Poly(adp-ribose) polymerase-1 regulates Tracp gene promoter activity during RANKL-induced osteoclastogenesis.

Beranger GE, Momier D, Rochet N, Carle GF, Scimeca JC.

J Bone Miner Res. 2008 Apr;23(4):564-71.

34.

Differential binding of poly(ADP-Ribose) polymerase-1 and JunD/Fra2 accounts for RANKL-induced Tcirg1 gene expression during osteoclastogenesis.

Beranger GE, Momier D, Guigonis JM, Samson M, Carle GF, Scimeca JC.

J Bone Miner Res. 2007 Jul;22(7):975-83.

35.

RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis.

Beranger GE, Momier D, Rochet N, Quincey D, Guigonis JM, Samson M, Carle GF, Scimeca JC.

J Bone Miner Res. 2006 Nov;21(11):1757-69.

36.

Interleukin-7 partially rescues B-lymphopoiesis in osteopetrotic oc/oc mice through the engagement of B220+ CD11b+ progenitors.

Blin-Wakkach C, Wakkach A, Quincey D, Carle GF.

Exp Hematol. 2006 Jul;34(7):851-9.

PMID:
16797412
37.

Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells.

Trojani C, Boukhechba F, Scimeca JC, Vandenbos F, Michiels JF, Daculsi G, Boileau P, Weiss P, Carle GF, Rochet N.

Biomaterials. 2006 Jun;27(17):3256-64. Epub 2006 Feb 28.

PMID:
16510180
38.

Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.

Blin-Wakkach C, Breuil V, Quincey D, Bagnis C, Carle GF.

Bone. 2006 Jul;39(1):53-60. Epub 2006 Feb 28.

PMID:
16503212
39.

A silanized hydroxypropyl methylcellulose hydrogel for the three-dimensional culture of chondrocytes.

Vinatier C, Magne D, Weiss P, Trojani C, Rochet N, Carle GF, Vignes-Colombeix C, Chadjichristos C, Galera P, Daculsi G, Guicheux J.

Biomaterials. 2005 Nov;26(33):6643-51.

PMID:
15950277
40.

Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydroxypropylmethylcellulose hydrogel.

Trojani C, Weiss P, Michiels JF, Vinatier C, Guicheux J, Daculsi G, Gaudray P, Carle GF, Rochet N.

Biomaterials. 2005 Sep;26(27):5509-17.

PMID:
15860207
41.

Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis.

Blin-Wakkach C, Wakkach A, Sexton PM, Rochet N, Carle GF.

Leukemia. 2004 Sep;18(9):1505-11.

PMID:
15284856
42.

Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.

Blin-Wakkach C, Wakkach A, Rochet N, Carle GF.

J Bone Miner Res. 2004 Jul;19(7):1137-43. Epub 2004 Mar 22.

43.

[Osteopetrosis, from mouse to man].

Blin-Wakkach C, Bernard F, Carle GF.

Med Sci (Paris). 2004 Jan;20(1):61-7. Review. French.

44.

Modification of gene expression induced in human osteogenic and osteosarcoma cells by culture on a biphasic calcium phosphate bone substitute.

Rochet N, Loubat A, Laugier JP, Hofman P, Bouler JM, Daculsi G, Carle GF, Rossi B.

Bone. 2003 Jun;32(6):602-10.

PMID:
12810167
45.

Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis.

Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, Gaudray P, Philip N, Fischer A, Carle GF.

Hum Mutat. 2003 Feb;21(2):151-7.

PMID:
12552563
46.

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML; Osteoporosis-Pseudoglioma Syndrome Collaborative Group.

Cell. 2001 Nov 16;107(4):513-23.

47.

The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants.

Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF.

Bone. 2000 Mar;26(3):207-13.

PMID:
10709991
48.

Report of the Sixth International Workshop on Human Chromosome 11 Mapping 1998. Nice, France, May 2-5, 1998.

Gaudray P, Carle GF, Gerhard DS, Gessler M, Mannens MM, Athanasiou M, Bliek J, Calender A, Debelenko LV, Devignes M, Evans GA, Favier R, Forbes S, Gaudray G, Gawin B, Gordon M, Grimmond S, Grossfeld P, Harris J, Hattori M, Hosoda F, Hummerich H, James M, Kalla J, Katsanis N, et al.

Cytogenet Cell Genet. 1999;86(3-4):167-86. No abstract available.

PMID:
10575203
49.

Structural analysis, expression, and chromosomal localization of the mouse ikba gene.

Rupec RA, Poujol D, Grosgeorge J, Carle GF, Livolsi A, Peyron JF, Schmid RM, Baeuerle PA, Messer G.

Immunogenetics. 1999 May;49(5):395-403.

PMID:
10199915
50.

Characterization of the mouse Men1 gene and its expression during development.

Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, Bergman L, Carle GF, Lemmens I, Grimmond S, Xian CZ, Khodei S, Teh BT, Lagercrantz J, Siggers P, Calender A, Van de Vem V, Kas K, Weber G, Hayward N, Gaudray P, Larsson C.

Oncogene. 1998 Nov 12;17(19):2485-93.

Supplemental Content

Loading ...
Support Center